https://www.pharmatutor.org/pharma-news/2025/astrazeneca-pharma-india-limited-and-sun-pharma-partner-to-help-patients-living-with-hyperkalaemia-in-india
AstraZeneca Pharma India Limited and Sun Pharma partner to help patients living with Hyperkalaemia...
AstraZeneca Pharma India Limited a leading science-led biopharmaceutical company and Sun Pharmaceutical Industries Limited today announced a second brand...
to helpliving withastrazenecapharmaindia
https://www.radcliffecardiology.com/video-index/controversies-hyperkalaemia-management-and-practical-approaches?language_content_entity=en&ep=28686&ch=28687
Controversies in Hyperkalaemia Management and Practical Approaches
Controversy is good. But when it comes to hyperkalaemia management, we need solutions. Chair, Prof Sydney Tang (University of Hong Kong, HK) Prof Chuan-Ming
controversieshyperkalaemiamanagementpracticalapproaches
https://www.clinicaltrialsarena.com/news/astrazeneca-halt-hyperkalaemia-trials/
AstraZeneca to halt Phase III hyperkalaemia trials of Lokelma
Dec 4, 2023 - AstraZeneca has announced plans for the discontinuation of two Phase III clinical trials of Lokelma being analysed for managing hyperkalaemia.
phase iiiastrazenecahalthyperkalaemiatrials
https://researchspace.ukzn.ac.za/items/36681f4e-b6cd-4859-8311-8e23956d72f1
A retrospective study to determine the prevalence and degree of hyperkalaemia in adult patients...
Chapter 1: Abstract Background: The presence of hyperkalaemia is a known risk factor for the development of cardiac rhythm disturbances and sudden cardiac...
retrospective studydetermineprevalencedegreehyperkalaemia
https://www.buzzsprout.com/1137521/episodes/17487364-hyperkalaemia-who-needs-admission-and-who-can-be-managed-in-the-community
Hyperkalaemia- who needs admission and who can be managed in the community?
Grab your trainers, your dog lead, or a cuppa and join us for some free CPD as we have another relaxed round up of recent Red Whale primary care Pearls of...
in the communityhyperkalaemianeedsadmissionmanaged